MX9702941A - Compuestos de di-ter - butilfenol que tiene una porcion heterociclica, utiles como agentes anti-inflamatorios. - Google Patents

Compuestos de di-ter - butilfenol que tiene una porcion heterociclica, utiles como agentes anti-inflamatorios.

Info

Publication number
MX9702941A
MX9702941A MX9702941A MX9702941A MX9702941A MX 9702941 A MX9702941 A MX 9702941A MX 9702941 A MX9702941 A MX 9702941A MX 9702941 A MX9702941 A MX 9702941A MX 9702941 A MX9702941 A MX 9702941A
Authority
MX
Mexico
Prior art keywords
tert
useful
inflammatory agents
heterocyclic moiety
butylphenol compounds
Prior art date
Application number
MX9702941A
Other languages
English (en)
Other versions
MXPA97002941A (es
Inventor
Michael Wiard Scherz
Stanislaw Pikul
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9702941A publication Critical patent/MX9702941A/es
Publication of MXPA97002941A publication Critical patent/MXPA97002941A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

El sujeto de la invencion se refiere a compuestos que tiene la estructura (I), en donde: a) cada R es independientemente alquilo que tiene de 1 a 7 átomos de carbono; b) Z es 0 o N-X; c) X se selecciona de hidrogeno, alquilo que tiene de 1 a aproximadamente 7 átomos de carbono, C(O)Y, C(S)Y, y SO2Y; d) Y se selecciona de R', OR' y NR'2; e) R' se selecciona de hidrogeno, alquilo que tiene de 1 a aproximadamente 7 átomos de carbono, y fenilo; la presente invencion también se refiere a composiciones farmacéuticas que comprenden los compuestos anteriores, y métodos para tratar la inflamacion o dolor usando los compuestos. (Ver Formula).
MXPA/A/1997/002941A 1994-10-20 1995-10-18 Compuestos de di-ter-butilfenol que tiene unaporcion heterociclica, utiles como agentesanti-inflamatorios MXPA97002941A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08326619 1994-10-20
US08/326,619 US5510361A (en) 1994-10-20 1994-10-20 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
PCT/US1995/012878 WO1996012710A1 (en) 1994-10-20 1995-10-18 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
MX9702941A true MX9702941A (es) 1997-07-31
MXPA97002941A MXPA97002941A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
FI971674A0 (fi) 1997-04-18
WO1996012710A1 (en) 1996-05-02
US5510361A (en) 1996-04-23
EP0787130A1 (en) 1997-08-06
KR970707108A (ko) 1997-12-01
AU3859895A (en) 1996-05-15
NO971789L (no) 1997-06-19
FI971674A (fi) 1997-04-18
KR100226509B1 (ko) 1999-10-15
NO971789D0 (no) 1997-04-18
JPH10507754A (ja) 1998-07-28
AU705645B2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
MX9701819A (es) Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiiflamatorios.
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
AU7578894A (en) Methods for inhibiting smooth muscle cell proliferation and restinosis
AU5165393A (en) Substituted benzylaminoquinuclidines as substance p antagonists
EP0948327A4 (en) ANTIDIABETIC AGENTS
NO971789L (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
HK1028021A1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
SI1000034T1 (en) Substituted 6-alkylphenanthridines
IL119069A0 (en) Pharmaceutical composition comprising tyrphostins
PL330408A1 (en) Dihydrobenzopyrane and affinite compounds useful as antiinflammatory agents
NZ322777A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
NZ501492A (en) Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia
NZ331618A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
CA2196054A1 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
MX9806252A (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.
MX9806249A (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.
MX9700726A (es) Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiinflamatorios.
HK1032916A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
SE9701912D0 (sv) Pharmaceutical composition and use thereof
MX9806247A (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios.
MY122562A (en) Antibacterial composition
IL138373A0 (en) New compounds
MY131931A (en) Methods of inhibiting primary endometrial hyperplasia
MY109672A (en) Azole compounds, their production and use

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees